Real-time enrollment status for this triple negative breast cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05633654 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 1,514 participants |
| Active Locations | 171 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | January 20, 2026 (Jan 20, 2026) |
As of March 2, 2026: Clinical trial NCT05633654 is currently recruiting participants. This clinical trial study for triple negative breast cancer is actively seeking new participants at 171 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05633654 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 171 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05633654 was last updated Jan 20, 2026 (January 20, 2026). HelloStudys verifies this status automatically.